mankind pharma block deal: 3 PE firms looking to sell 5-6% stake in Mankind Pharma via block deals: Report
Kotak Mahindra Capital is one of the advisors to the deal, and the private equity investors are offering a discount of upto 7% from the current price. The floor price has been set at Rs 1,785.65 a share.